An aerial view shows modern medical buildings lining the main axis, tropical landscaping, and a helipad—illustrating the scale and openness of the Boao Lecheng International Medical Tourism Pilot Zone.
Aerial view of Boao Lecheng: futuristic campus and medical facilities

This news belongs to Lexaid’s featured hospital profile for Boao Lecheng (Boao, Qionghai, Hainan · State Council–approved international medical tourism pilot zone), curated for international patients exploring care pathways in China.
About this hospital
Hospital context for international patients
Boao Lecheng
Boao Lecheng International Medical Tourism Pilot Zone · licensed innovative therapies
- Level
- State Council–approved international medical tourism pilot zone
- Founded
- 2013
- Address
- Boao, Qionghai, Hainan
Boao Lecheng International Medical Tourism Pilot Zone, Qionghai, Hainan (Wanquan River estuary)
Phone:+86 185 2131 5346
Email:[email protected]
The Hainan Boao Lecheng International Medical Tourism Pilot Zone was approved by China’s State Council in February 2013 in Boao, Qionghai, Hainan—widely described as China’s only “medical special zone.” Policy priorities include licensed specialty care, health management, rehab/nursing, and medical aesthetics within an international medical-tourism framework.
Under “licensed medical care, research, operations, and international medical exchange” policies, designated institutions inside the zone may—after regulatory approval—import and use certain clinically urgently needed drugs and devices already marketed overseas but not yet registered on the Chinese mainland. Access is limited to approved hospitals and indications in the zone, not a nationwide open pathway.
Xinhua and Qiushi reporting cite roughly 36 operating medical institutions (including foreign-invested ones), anchored by leading public hospitals such as Ruijin Hospital Hainan campus and West China–related partnerships, plus a real-world data pilot that supports faster domestic registration of innovative products.
Key departments
- Ruijin Hospital Hainan campus (public)
- Oncology & precision medicine
- Rare & complex diseases
- Stem-cell / cell & gene pathways
- Health management & executive checkup
- Rehab wellness & medical aesthetics
- Real-world evidence & access
Featured care
Licensed drugs & devices—“triple sync” access
Official coverage says the zone has largely achieved “triple sync” of technologies, equipment, and drugs with international advances. Xinhua (Mar 2025) cited 460+ overseas-approved products not yet mainland-registered; Qiushi (Oct 2025) cited 512 innovative products and 180,000+ patient visits benefited. Always verify the current licensed list and hospital approvals.
Top public hospitals + specialty brands
A cluster led by top public hospitals such as Ruijin and West China networks, plus branded specialty institutions—strengthening oncology, rare-disease, and related capabilities.
Real-world evidence accelerating access
As a real-world data pilot, Lecheng converts licensed clinical use into evidence supporting domestic registration. Reports cite multiple products entering the China market via the pilot, with some later included in national reimbursement lists.
More stories from this hospital
Ready to explore this hospital pathway?
Tell us your condition and travel window—Lexaid / Qile Wuyou (上海其乐无忧科技有限公司) will help coordinate matching, records, and next steps via WhatsApp, email, or WeChat.
Information is compiled from public sources for reference only and is not medical advice. Confirm pathways, fees, and appointments with the hospital in writing.
